These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11509159)

  • 21. Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study.
    Johnson SL; Tierney EF; Onyemere KU; Tseng CW; Safford MM; Karter AJ; Ferrara A; Duru OK; Brown AF; Narayan KM; Thompson TJ; Herman WH
    Diabetes Care; 2006 Aug; 29(8):1733-8. PubMed ID: 16873772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical practice. Nephropathy in patients with type 2 diabetes.
    Remuzzi G; Schieppati A; Ruggenenti P
    N Engl J Med; 2002 Apr; 346(15):1145-51. PubMed ID: 11948275
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence.
    Scheid DC; McCarthy LH; Lawler FH; Hamm RM; Reilly KE
    J Fam Pract; 2001 Aug; 50(8):661-8. PubMed ID: 11509158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of urinary albumin excretion in arterial hypertension].
    de la Sierra A; Divisón JA; Garrido P; Barbón A; Arístegui R;
    Rev Clin Esp; 2012 Apr; 212(4):172-8. PubMed ID: 22176929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure control: time for action.
    Lantelme P
    Arch Cardiovasc Dis; 2009; 102(6-7):465-7. PubMed ID: 19664564
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diabetes, hypertension and microalbuminuria in primary care].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():33-8. PubMed ID: 14732948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic nephropathy: common questions.
    Thorp ML
    Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes in Indonesia.
    Sja'bani M; Asdie AH; Widayati K; Subroto Y; Kariadi SH; Arifin AY; Adhiarta IG; Permana H; T A; Hendromartono ; Adi S; Wibisono S; Murtiwi S
    Acta Med Indones; 2005; 37(4):199-204. PubMed ID: 16354940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B; Weidmann P; Wohler D; Le Bloch Y
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
    Dietrich W; Blumenstein M
    MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026
    [No Abstract]   [Full Text] [Related]  

  • 33. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
    Cortés-Sanabria L; Martínez-Ramírez HR; Hernández JL; Rojas-Campos E; Canales-Muñoz JL; Cueto-Manzano AM
    Rev Invest Clin; 2006; 58(3):190-7. PubMed ID: 16958293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines adherence and hypertension control at a tertiary hospital in Malaysia.
    Ahmad N; Hassan Y; Tangiisuran B; Meng OL; Abd Aziz N; Ahmad FU; Atif M
    J Eval Clin Pract; 2013 Oct; 19(5):798-804. PubMed ID: 22583820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician compliance with colon cancer screening.
    Malik J; Sansone RA
    Am J Gastroenterol; 2002 Apr; 97(4):1078-9. PubMed ID: 12003406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.